Correlation of metabolism, covalent binding and toxicity for a series of bromobenzene derivatives using rat liver slices in vitro.

For many acute-acting chemicals, toxic responses observed in vivo correlate strongly with metabolic activation and macromolecular covalent binding (CVB) observed in vitro and often in vivo; bromobenzene (BB) is a classic example of this behavior. Substituent groups modulate the toxicity of bromobenzene in vivo and in liver slices cultured in vitro in parallel fashion [Fisher, R., Hanzlik, R.P., Gandolfi, J.A., and Brendel, K. (1992), In Vitro Toxicology, 4, 173-186]. In the present study we used the liver slice system to examine the relationship between toxicity, metabolism and covalent binding amongst a series of [3H/14C] dual labelled BB derivatives including (in order of increasing hepatotoxicity) o-bromoanisole (BA), o-bromotoluene (BT), o-bromobenzonitrile (BBN), BB and o-dibromobenzene (DBB). Among these congeners apparent relative rates of metabolism varied only 4-fold, but the most extensively metabolized compounds were the least toxic. CVB varied 7-fold across the series, and those compounds which bound the most frequently were the most toxic. For each compound the relative binding index (RBI = pmol bound/nmol metabolized) and the average retention of tritium relative to carbon-14 in the CVB fraction were constant throughout the 24 h incubations, suggesting that the metabolic profile of each compound remained constant with time. The RBI values, however, did not reflect relative toxicity as well as total CVB values. The T/C ratios of the CVB residues varied from 0.36 (for BA) to 0.81 (for BBN), indicating that ortho-substitution on BB exerts important qualitative as well as quantitative effects on overall metabolism and reactive metabolite formation. The finding that relative toxicity among a series of bromobenzene congeners is paralleled by their relative covalent binding measured in the same system in which toxicity is assessed adds support to the hypothesis that covalent binding contributes to the observed toxicity, rather than merely being a correlated epiphenomenon.

[1]  B. Merrick,et al.  Effect of sodium selenite upon bromobenzene toxicity in rats. II. Metabolism. , 1986, Toxicology and applied pharmacology.

[2]  C. Klaassen,et al.  Comparison of the effects of metals on cellular injury and lipid peroxidation in isolated rat hepatocytes. , 1981, Journal of toxicology and environmental health.

[3]  M. Turner,et al.  The metabolism and excretion of mononitrotoluenes by Fischer 344 rats. , 1984, Drug metabolism and disposition: the biological fate of chemicals.

[4]  A. J. Gandolfi,et al.  In vitro cytotoxicity of allyl alcohol and bromobenzene in a novel organ culture system. , 1987, Toxicology and applied pharmacology.

[5]  G. Krishna,et al.  Centrolobular hepatic necrosis related to covalent binding of metabolites of halogenated aromatic hydrocarbons. , 1973, Experimental and molecular pathology.

[6]  M. Eichelbaum,et al.  3-Methylcholanthrene blocks hepatic necrosis induced by administration of bromobenzene or carbon tetrachloride. , 1971, Experimental and molecular pathology.

[7]  D. Jollow,et al.  Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. , 1974, Pharmacology.

[8]  R. Billings.  Mechanisms of catechol formation from aromatic compounds in isolated rat hepatocytes. , 1985, Drug Metabolism And Disposition.

[9]  R. Hanzlik,et al.  Effect of substituents on arene oxide-mediated liver toxicity among substituted bromobenzenes. , 1977, Toxicology and applied pharmacology.

[10]  P. Weller,et al.  Synthesis of substituted bromobenzene derivatives via bromoanilines. A moderately selective ortho-bromination of [14c]-aniline , 1988 .

[11]  J. Joly,et al.  Effect of chronic ethanol administration on bromobenzene liver toxicity in the rat. , 1983, Toxicology and applied pharmacology.

[12]  R. G. Lamb,et al.  The effects of bromobenzene and carbon tetrachloride exposure in vitro on the phospholipase C activity of rat liver cells. , 1982, Toxicology and applied pharmacology.

[13]  C. Krumdieck,et al.  A new instrument for the rapid preparation of tissue slices. , 1980, Analytical biochemistry.

[14]  S. Orrenius,et al.  Metabolic activation and hepatotoxicity: Metabolism of bromobenzene in isolated hepatocytes☆ , 1978 .

[15]  S. Orrenius,et al.  Metabolic activation and hepatotoxicity. Toxicity of bromobenzene in hepatocytes isolated from phenobarbital-and diethylmaleate-treated rats. , 1978, Archives of biochemistry and biophysics.

[16]  R. Hanzlik,et al.  Dihydroxylated mercapturic acid metabolites of bromobenzene. , 1992, Chemical research in toxicology.

[17]  R. Harbison,et al.  Antagonism of bromobenzene-induced hepatotoxicity by the alpha-adrenergic blocking agents, phentolamine and idazoxan. , 1988, Toxicology and applied pharmacology.

[18]  A. J. Gandolfi,et al.  Chromatographic resolution of amino acid adducts of aliphatic halides. , 1982, Chemico-biological interactions.

[19]  D. Taylor,et al.  The role of phospholipid metabolism in bromobenzene- and carbon tetrachloride-dependent hepatocyte injury. , 1984, Toxicology and applied pharmacology.

[20]  I. Sipes,et al.  Biliary excretion of metabolities of bromobenzene. , 1974, Biochemical pharmacology.

[21]  E. C. Rietveld,et al.  Mercapturic acids as metabolites of aromatic aldehydes and alcohols. , 1981, Advances in experimental medicine and biology.

[22]  R P Mason,et al.  Redox cycling and sulphydryl arylation; their relative importance in the mechanism of quinone cytotoxicity to isolated hepatocytes. , 1988, Chemico-biological interactions.

[23]  T. Monks,et al.  The contribution of bromobenzene to our current understanding of chemically-induced toxicities. , 1988, Life sciences.

[24]  R. Hanzlik,et al.  Effect of substituents on in vitro metabolism and covalent binding of substituted bromobenzenes. , 1979, Toxicology and applied pharmacology.

[25]  J R Gillette,et al.  Role of detoxifying enzymes in bromobenzene-induced liver necrosis. , 1973, The Journal of pharmacology and experimental therapeutics.

[26]  P. Weller,et al.  Microsomal metabolism and covalent binding of [3H/14C]-bromobenzene. Evidence for quinones as reactive metabolites. , 1988, Xenobiotica; the fate of foreign compounds in biological systems.

[27]  A. Casini,et al.  Liver glutathione depletion induced by bromobenzene, iodobenzene, and diethylmaleate poisoning and its relation to lipid peroxidation and necrosis. , 1985, The American journal of pathology.

[28]  A. J. Gandolfi,et al.  Toxicity of chlorobenzenes in cultured rat liver slices , 1990 .

[29]  M. Younes,et al.  Interrelation between lipid peroxidation and other hepatotoxic events. , 1984, Biochemical pharmacology.

[30]  J R Gillette,et al.  Stereoselective formation of bromobenzene glutathione conjugates. , 1982, Chemico-biological interactions.

[31]  I. Sipes,et al.  Metabolism of dichlorobenzenes in organ cultured liver slices. , 1991, Advances in experimental medicine and biology.

[32]  R. Hanzlik,et al.  Toxicity of ortho-substituted bromobenzenes to isolated hepatocytes: comparison to in vivo results. , 1983, Toxicology and applied pharmacology.

[33]  S. Orrenius,et al.  Role of Ca2+ in toxic cell killing. , 1989, Trends in pharmacological sciences.

[34]  A Casini,et al.  Mechanisms of cell injury in the killing of cultured hepatocytes by bromobenzene. , 1982, The Journal of biological chemistry.

[35]  T. Slater.  Free-radical mechanisms in tissue injury. , 1984, The Biochemical journal.

[36]  B B Brodie,et al.  Possible mechanism of liver necrosis caused by aromatic organic compounds. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[37]  B. Lane,et al.  Effects of diphenyl-phenylenediamine on gentamicin-induced lipid peroxidation and toxicity in rat renal cortex. , 1986, The Journal of pharmacology and experimental therapeutics.

[38]  D. Liebler,et al.  Enzymatic activation of chemicals to toxic metabolites. , 1985, Critical reviews in toxicology.

[39]  B. Brodie,et al.  Bromobenzene metabolism and hepatic necrosis. , 1971, Pharmacology.

[40]  T. Monks,et al.  Bromobenzene and p-bromophenol toxicity and covalent binding in vivo. , 1982, Life sciences.

[41]  S. Orrenius,et al.  Menadione-induced bleb formation in hepatocytes is associated with the oxidation of thiol groups in actin. , 1988, Archives of biochemistry and biophysics.

[42]  R. Hanzlik,et al.  Identification of epoxide- and quinone-derived bromobenzene adducts to protein sulfur nucleophiles. , 1991, Chemical research in toxicology.

[43]  R. Hanzlik,et al.  N-dealkylation of tertiary amides by cytochrome P-450. , 1991, Xenobiotica; the fate of foreign compounds in biological systems.

[44]  T. Wolff,et al.  Involvement of phenolic metabolites in the irreversible protein-binding of 14C-bromobenzene catalysed by rat liver microsomes. , 1980, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

[45]  B. Merrick,et al.  Effect of sodium selenite upon bromobenzene toxicity in rats. I. Hepatotoxicity. , 1986, Toxicology and applied pharmacology.

[46]  B. Brodie,et al.  Bromobenzene-induced hepatic necrosis: species differences and protection by SKF 525-A. , 1971, Research communications in chemical pathology and pharmacology.